Dokter Lindsay Jongman: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dokter Lindsay Jongman
Largest movements
- Cash +€360,721
up €360,721 (+36,072%), from €1,000 to €361,721
mainly Receivables within one year (+€215,763) and Net result for the year (+€118,677)
- Receivables within one year -€215,763
down €215,763 (-71.2%), from €303,169 to €87,406
of which Other amounts receivable: -€226,474
- Deferred charges and accrued income +€13,678
new in 2025: €13,678
- Reserves +€118,677
up €118,677 (+52.6%), from €225,682 to €344,359
- Tax, wage and social debts +€33,270
up €33,270 (+48.5%), from €68,561 to €101,830
- Trade debts +€6,689
up €6,689 (+74.9%), from €8,927 to €15,615
- Gross operating margin -€142,978
down €142,978 (-48.5%), from €294,596 to €151,618
- Taxes -€35,291
down €35,291 (-51.5%), from €68,561 to €33,270
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €304,169 | €462,805 | +€158,635 | +52.2% |
| Current assets | 29/58 | €304,169 | €462,805 | +€158,635 | +52.2% |
| Amounts receivable within one year | 40/41 | €303,169 | €87,406 | -€215,763 | -71.2% |
| Trade receivables | 40 | €49,558 | €60,269 | +€10,711 | +21.6% |
| Other amounts receivable | 41 | €253,611 | €27,137 | -€226,474 | -89.3% |
| Cash at bank and in hand | 54/58 | €1,000 | €361,721 | +€360,721 | +36,072% |
| Deferred charges and accrued income | 490/1 | - | €13,678 | +€13,678 | |
| Total equity and liabilities | 10/49 | €304,169 | €462,805 | +€158,635 | +52.2% |
| Equity | 10/15 | €226,682 | €345,359 | +€118,677 | +52.4% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €225,682 | €344,359 | +€118,677 | +52.6% |
| Distributable reserves | 133 | €225,682 | €344,359 | +€118,677 | +52.6% |
| Amounts payable | 17/49 | €77,487 | €117,445 | +€39,958 | +51.6% |
| Amounts payable within one year | 42/48 | €77,487 | €117,445 | +€39,958 | +51.6% |
| Trade debts | 44 | €8,927 | €15,615 | +€6,689 | +74.9% |
| Suppliers | 440/4 | €8,927 | €15,615 | +€6,689 | +74.9% |
| Taxes, remuneration and social security | 45 | €68,561 | €101,830 | +€33,270 | +48.5% |
| Taxes | 450/3 | €68,561 | €101,830 | +€33,270 | +48.5% |
| Other operating charges | 640/8 | €588 | €640 | +€52 | +8.8% |
| Gross operating margin | 9900 | €294,596 | €151,618 | -€142,978 | -48.5% |
| Operating profit (loss) | 9901 | €294,008 | €150,978 | -€143,030 | -48.6% |
| Financial income | 75/76B | €261 | €1,044 | +€783 | +300% |
| Recurring financial income | 75 | €261 | €1,044 | +€783 | +300% |
| Financial charges | 65/66B | €27 | €75 | +€48 | +181% |
| Recurring financial charges | 65 | €27 | €75 | +€48 | +181% |
| Profit (loss) for the period before taxes | 9903 | €294,242 | €151,947 | -€142,295 | -48.4% |
| Income taxes | 67/77 | €68,561 | €33,270 | -€35,291 | -51.5% |
| Profit (loss) for the period | 9904 | €225,682 | €118,677 | -€107,004 | -47.4% |
| Profit (loss) for the period to be appropriated | 9905 | €225,682 | €118,677 | -€107,004 | -47.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.